Story perspectives

J&J Faces $40M Verdict Over Talcum Powder Cancer Claims

12/16/2025

27 5

Summary

Story summary

A Los Angeles jury awarded $40 million to two women who claim Johnson & Johnson’s talcum powder caused their ovarian cancer.
Johnson & Johnson plans to appeal the verdict amid ongoing legal disputes regarding the talc-cancer link.
The company halted global sales of talc-based powder in 2023 after a jury ordered $966 million in damages in a similar case.
The Treasury Department is investigating fraud in Minnesota’s Somali community, requiring money wire services to enhance verification.
This investigation follows allegations that a nonprofit misappropriated $300 million in pandemic aid, potentially benefiting al-Shabab.

1 of 1

Story summary

A Los Angeles jury awarded $40 million to two women who claim Johnson & Johnson’s talcum powder caused their ovarian cancer.
Johnson & Johnson plans to appeal the verdict amid ongoing legal disputes regarding the talc-cancer link.
The company halted global sales of talc-based powder in 2023 after a jury ordered $966 million in damages in a similar case.
The Treasury Department is investigating fraud in Minnesota’s Somali community, requiring money wire services to enhance verification.
This investigation follows allegations that a nonprofit misappropriated $300 million in pandemic aid, potentially benefiting al-Shabab.